Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
USFDA issues import alert for Ranbaxy Mohali facilities
Description
In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this
More from User
06:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
01:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint
Related Videos
03:33
FDA charges data integrity issues in Wockhardt factories
Mint
01:42
SpiceJet to take tough decisions on strategic operations issues soon
Mint
04:01
Money Minutes | Two tax free bond issues hit the market
Mint
00:44
Kashmir crisis meet: Key issues discussed
Mint
01:08
Indian high yield bond issues surge to record highs
Mint
03:25
Ten Bollywood films on political issues
Mint